VPIM
FLNA

Vanguard Personalized Indexing Management’s Filana Therapeutics FLNA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.5K Buy
13,891
+1,026
+8% +$2.11K ﹤0.01% 2114
2025
Q4 		$25.5K Sell
12,865
-236
-2% -$756 ﹤0.01% 1928
2025
Q3 		$38.1K Buy
13,101
+236
+2% +$543 ﹤0.01% 1933
2025
Q2 		$23.3K Buy
+12,865
New +$22.9K ﹤0.01% 1897

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Vanguard Personalized Indexing Management's FLNA Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Filana Therapeutics (FLNA) stake by 8% in Q1 2026, buying an estimated $2.11K and bringing the position to 13,891 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Vanguard Personalized Indexing Management first reported a position in FLNA in Q2 2025 and has held it in 4 quarters since. The position peaked at $38.1K in Q3 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Vanguard Personalized Indexing Management held 13,891 shares of Filana Therapeutics worth $23.5K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 1,026 Filana Therapeutics shares in Q1 2026, an estimated $2.11K.
  • Filana Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2114 holding.
  • Vanguard Personalized Indexing Management first reported a position in Filana Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Vanguard Personalized Indexing Management's Filana Therapeutics position peaked at $38.1K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.